Optimization and characterization of gastroretentive floating drug delivery system using Box-Behnken design

References

• Khosla R, Davis SS. The effect of tablet size on gastric emptying of nondisintegnating tablet. Int J Pharm 1990;62: 31–42.
   Google Scholar
• Mojaverian P, Viasses PH, Kellner PE, Rocci ML. Effects of gender, posture and age on gastric residence time of an indigestible solid phamaceutical consideration. Pharm Res 1988;10: 363–644.
   Google Scholar
• Asnaashari S, Nazaninossadat SK, Zarrintan MH, Khosro A, Yousef J. Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets. Pharm Dev Technol. 2011;16:400–407.
   PubMed Web of Science ®Google Scholar
• Kalpana S, Satyanarayan P, Subrata M, Appana CK. Influence of hydroxypropyl methylcellulose on drug release pattern of a gastroretentive floating drug delivery system using a 32 full factorial design. Pharm Dev Technol 2009;14:193–198.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Sánchez PE, Hernández-León A, Villafuerte-Robles L. (2008). Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets. Drug Dev Ind Pharm, 34:171–180.
   PubMed Web of Science ®Google Scholar
• Gangadharappa HV, Rahamath-Ulla M, Pramod-Kumar TM, Shakeel F. Floating drug delivery system of verapamil hydrochloride using karaya gum and HPMC. Clin Res Regul Aff 2010;27:13–20.
   Google Scholar
• Klacsner EA, Friedman M, Hoffman A. Expandable gastroretentive dosage form. J Control Release 2003;90:143–162.
   PubMed Web of Science ®Google Scholar
• Klausner EA, Eyal S, Lavy E, Friedman M, Hoffman A. (2003). Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs. J Control Release, 88:117–126.
   PubMed Web of Science ®Google Scholar
• Klausner EA, Lavy E, Barta M, Cserepes E, Friedman M, Hoffman A. (2003). Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on levodopa absorption in humans. Pharm Res, 20:1466–1473.
   PubMed Web of Science ®Google Scholar
• Curatolo WJ, Lo J. Gastric retention drug system for controlled drug release, US patent 5443843, August 22, 1995.
   Google Scholar
• Sonobe T, Watanabe S, Katsuma M, Takamatsu N, Konno Y, Takagi H. Gastric retention device. Eur patent 0415671, March 13, 1991.
   Google Scholar
• Chen J, Blevins WE, Park H, Park K. (2000). Gastric retention properties of superporous hydrogel composites. J Control Release, 64:39–51.
   PubMed Web of Science ®Google Scholar
• Chen J, Park K. (2000). Synthesis and characterization of superporous hydrogel composites. J Control Release, 65:73–82.
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JH, Robinson JR. (2000). Bioadhesive-based dosage forms: the next generation. J Pharm Sci, 89:850–866.
   PubMed Web of Science ®Google Scholar
• Chun MK, Sah H, Choi HK. (2005). Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori. Int J Pharm, 297:172–179.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A. Mucoadhesive systems in oral drug delivery. Drug Discov Today Tech, 2005;2:83–87.
   PubMedGoogle Scholar
• Chowdary KP, Rao YS. (2004). Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull, 27:1717–1724.
   PubMed Web of Science ®Google Scholar
• Säkkinen M, Marvola J, Kanerva H, Lindevall K, Lipponen M, Kekki T et al. (2004). Gamma scintigraphic evaluation of the fate of microcrystalline chitosan granules in human stomach. Eur J Pharm Biopharm, 57:133–143.
   PubMed Web of Science ®Google Scholar
• Ito R, Machida Y, Sannan T, Nagai T. Magnetic granules: a novel system for specific drug delivery to esophageal mucosa in oral administration. Int J Pharm. 1990;61:109–117.
   Web of Science ®Google Scholar
• Fujimori J, Machida Y, Nagai T. Preparation of a magnetically responsive tablet and confirmation o f its gastric residence in beagle dogs. STP Pharma Sci 1994;4:425–430.
   Google Scholar
• Groning R, Berntgen M. (1996). Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule. Pharmazie, 51:328–331.
   PubMed Web of Science ®Google Scholar
• Gröning R, Berntgen M, Georgarakis M. (1998). Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. Eur J Pharm Biopharm, 46:285–291.
   PubMed Web of Science ®Google Scholar
• Moes AJ. Gastric retention systems for oral drug delivery, Business Briefing. PharmaTech 2003;157–159.
   Google Scholar
• Garg S, Sharma S. Gastroretentive drug delivery systems, Business Briefing. PharmaTech 2003;160–166.
   Google Scholar
• Jaleh V, Tavakoli N, Roozbahani F. Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Delivery, 2006; 13:277–285.
   PubMed Web of Science ®Google Scholar
• Abubakr ON, Jun SZ. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev Ind Pharm, 2000; 26:965–969.
   PubMed Web of Science ®Google Scholar
• Chueh HR, Zia H, Rhodes CT. Optimization of sotalol floating and bioadhesive extended release tablet formulations, Drug Dev Ind Pharm, 1995;21:1725–1747.
   Web of Science ®Google Scholar
• Whitehead L, Fell JT, Collett JH, Sharma HL, Smith A. (1998). Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Release, 55:3–12.
   PubMed Web of Science ®Google Scholar
• Singh BN, Kim KH. (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release, 63:235–259.
   PubMed Web of Science ®Google Scholar
• Arora S, Ali J, Ahuja A, Khar RK, Baboota S. (2005). Floating drug delivery systems: a review. AAPS PharmSciTech, 6:E372–E390.
   PubMed Web of Science ®Google Scholar
• Bardonnet PL, Faivre V, Pugh WJ, Piffaretti JC, Falson F. (2006). Gastroretentive dosage forms: overview and special case of Helicobacter pylori. J Control Release, 111:1–18.
   PubMed Web of Science ®Google Scholar
• Brahma N, Kwon HK. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 2000;63:235–259.
   PubMed Web of Science ®Google Scholar
• Rouge N, Buio P, Doelker E, Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm, 1996;136: 117–139.
   Web of Science ®Google Scholar
• Vivek KP, Shaswat K, Garima G, Rajendra A, Deepak S, Giriraj TK. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug Delivery, 2011;18: 97–110.
   PubMed Web of Science ®Google Scholar
• Igor L, Natasa K, Ales M, Marija B. Gastric emptying of non-disintegrating solid drug delivery systems in fasted state: relevance to drug dissolution. Expert Opin Drug Delivery, 2010;8:967–976.
   Google Scholar
• Cooreman MP, Krausgrill P, Hengels KJ. (1993). Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother, 37:1506–1509.
   PubMed Web of Science ®Google Scholar
• Yang L, Eshraghi J, Fassihi R. (1999). A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation. J Control Release, 57:215–222.
   PubMed Web of Science ®Google Scholar
• Umamaheshwari RB, Jain S, Bhadra D, Jain NK. (2003). Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm Pharmacol, 55:1607–1613.
   PubMed Web of Science ®Google Scholar
• Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm, 1996;136:117–139.
   Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. (2004). In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int J Pharm, 275:97–107.
   PubMed Web of Science ®Google Scholar
• Seta Y, Higuchi F, Kawahara Y, Nishimura K, Okada R. Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties. Int J Pharm, 1988;41:245–254.
   Google Scholar
• Jain SK, Awasthi AM, Jain NK, Agrawal GP. (2005). Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J Control Release, 107:300–309.
   PubMed Web of Science ®Google Scholar
• Wurster DE, Alkhamis KA, Matheson LE. (2003). Prediction of the adsorption of diazepam by activated carbon in aqueous media. J Pharm Sci, 92:2008–2016.
   PubMed Web of Science ®Google Scholar
• Munday DL. (2003). Film coated pellets containing verapamil hydrochloride: enhanced dissolution into neutral medium. Drug Dev Ind Pharm, 29:575–583.
   PubMed Web of Science ®Google Scholar
• Chopra S, Patil GV, Motwani SK. (2007). Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design. Eur J Pharm Biopharm, 66:73–82.
   PubMed Web of Science ®Google Scholar
• Chopra S, Motwani SK, Iqbal Z, Talegaonkar S, Ahmad FJ, Khar RK. (2007). Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design. Eur J Pharm Biopharm, 67:120–131.
   PubMed Web of Science ®Google Scholar
• Box GEP, Behnken DW. Some new three level designs for the study of quantitative variables. Technometrics 1960;2: 455–475.
   Google Scholar
• Min SK, Jeong SK, Yeon HY, Hee JP, Sibeum L, Jeong SP, et al. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology. Int J Pharm 2007;341:97–104.
   PubMedGoogle Scholar
• Belem LH, Alejandra HL, Leopoldo VR. (2009). Effect of stearic acid on the properties of metronidazole /methocel K4M floating matrices. Braz J Pharm Sci, 45:495–505.
   Google Scholar
• Girish SS, Devendra KJ, Dhananjay MM. Preparation and in vitro evaluation of bilayer and floating bioadhesive tablets of rosiglitazone maleate. Asian J Pharm Sci, 2007;2:161–169.
   Google Scholar
• Jain SK, Awasthi AM, Jain NK, Agrawal GP. (2005). Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J Control Release, 107:300–309.
   PubMed Web of Science ®Google Scholar
• Srinivas M, Krishna S, Prabhakar RV. Design and evaluation of hydrochlorthiazide gastroretentive floating drug delivery system. Asian J Pharm Sci, 2011; 6:208–217.
   Google Scholar
• Nutan MT, Soliman MS, Taha EI, Khan MA. (2005). Optimization and characterization of controlled release multi-particulate beads coated with starch acetate. Int J Pharm, 294:89–101.
   PubMed Web of Science ®Google Scholar
• Shruti CH, Gayathri VP, Sanjay KM. Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design. Eur J Pharm Biopharm 2007;66: 73–82.
   PubMed Web of Science ®Google Scholar
• Paterakis PG, Korakianiti ES, Dallas PP, Rekkas DM. (2002). Evaluation and simultaneous optimization of some pellets characteristics using a 3(3) factorial design and the desirability function. Int J Pharm, 248:51–60.
   PubMed Web of Science ®Google Scholar